Genetic variants associated with quantitative glucose homeostasis traits translate to type 2 diabetes in Mexican Americans: The GUARDIAN (Genetics underlying diabetes in Hispanics) consortium

Diabetes

Volumn 64, Issue 5, 2015, Pages 1853-1866

  Palmer, Nicholette D ^a   Goodarzi, Mark O ^b   Langefeld, Carl D ^a   Wang, Nan ^c   Guo, Xiuqing ^d   Taylor, Kent D ^d   Fingerlin, Tasha E ^e   Norris, Jill M ^e   Buchanan, Thomas A ^c   Xiang, Anny H ^f   Haritunians, Talin ^b   Ziegler, Julie T ^a   Williams, Adrienne H ^a   Stefanovski, Darko ^b   Cui, Jinrui ^b   Mackay, Adrienne W ^c   Henkin, Leora F ^a   Bergman, Richard N ^b   Gao, Xiaoyi ^c,g   Gauderman, James ^c,g   Varma, Rohit ^g   Hanis, Craig L ^h   Cox, Nancy J ⁱ   Highland, Heather M ^h   Below, Jennifer E ^h   Williams, Amy L ^j,k,l   Burtt, Noel P ^j   Aguilar Salinas, Carlos A ^m   Huerta Chagoya, Alicia ^m,n   Gonzalez Villalpando, Clicerio ^o   Orozco, Lorena ^p   Haiman, Christopher A ^c   Tsai, Michael Y ^q   Johnson, W Craig ^r   Yao, Jie ^d   Rasmussen Torvik, Laura ^s   Pankow, James ^t   Snively, Beverly ^a   Jackson, Rebecca D ^u   Liu, Simin ^v   Nadler, Jerry L ^w   Kandeel, Fouad ^a   Chen, Yii Der I ^d   Bowden, Donald W ^a,x   Rich, Stephen S ^x   Raffel, Leslie J ^b   Rotter, Jerome I ^d   Watanabe, Richard M ^c   Wagenknecht, Lynne E ^a   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e Global Health and Health Disparities   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^h UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF CHICAGO   (United States)

^j BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^k HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^l Och Spine at New York Presbyterian Hospitals   (United States)

^m INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

ⁿ UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^o INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^p INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

^q UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^r UNIVERSITY OF WASHINGTON   (United States)

^s NORTHWESTERN UNIVERSITY   (United States)

^t THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^u BROWN UNIVERSITY   (United States)

^v EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^w Brown University ^*  (United States)

^x UNIVERSITY OF VIRGINIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CDK5 REGULATORY SUBUNIT ASSOCIATED PROTEIN 1 LIKE 1 GENE PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; INSULIN; MELATONIN 1 RECEPTOR; MELATONIN 1B RECEPTOR; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE HOMEOSTASIS; GROUPS BY AGE; HEREDITY; HUMAN; INSULIN BLOOD LEVEL; INSULIN CLEARANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MAJOR CLINICAL STUDY; MALE; MEXICAN AMERICAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE TRAIT LOCUS; SEX DIFFERENCE; ETHNOLOGY; FACTUAL DATABASE; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENETICS; GENOME; GENOTYPE; GLUCOSE BLOOD LEVEL; HISPANIC; HOMEOSTASIS; METABOLISM; PHYSIOLOGY;

BLOOD GLUCOSE; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION REGULATION; GENETIC VARIATION; GENOME; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISPANIC AMERICANS; HOMEOSTASIS; HUMANS;

EID: 84969321555     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-0732     Document Type: Article

References (51)

1. Lorenzo C, Wagenknecht LE, D'Agostino RB Jr, Rewers MJ, Karter AJ, Haffner SM. Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: The Insulin Resistance Atherosclerosis Study. Diabetes Care 2010;33:67-72.
2. Lee CC, Haffner SM, Wagenknecht LE, et al. Insulin clearance and the incidence of type 2 diabetes in Hispanics and African Americans: The IRAS Family Study. Diabetes Care 2013;36:901-907.
3. Voight BF, Scott LJ, Steinthorsdottir V, et al.; MAGIC Investigators; GIANT Consortium. Twelve type 2 diabetes susceptibility loci identified through largescale association analysis. Nat Genet 2010;42:579-589.
4. McCarthy MI. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010; 363:2339-2350.
5. DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-687.
6. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-748.
7. Rich SS, Bowden DW, Haffner SM, et al.; Insulin Resistance Atherosclerosis Study Family Study. Identification of quantitative trait loci for glucose homeostasis: The Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2004;53:1866-1875.
8. Watanabe RM, Valle T, Hauser ER, et al. Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland- United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered 1999;49:159-168.
9. Goodarzi MO, Taylor KD, Guo X, et al. Variation in the gene for musclespecific AMP deaminase is associated with insulin clearance, a highly heritable trait. Diabetes 2005;54:1222-1227.
10. Xiang AH, Azen SP, Raffel LJ, et al. Evidence for joint genetic control of insulin sensitivity and systolic blood pressure in Hispanic families with a hypertensive proband. Circulation 2001;103:78-83.
11. Dupuis J, Langenberg C, Prokopenko I, et al.; DIAGRAM Consortium; GIANT Consortium; Global BPgen Consortium; Anders Hamsten on behalf of Procardis Consortium; MAGIC Investigators. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet 2010;42:105- 116.
12. Manning AK, Hivert MF, Scott RA, et al.; DIAbetes Genetics Replication And Meta- Analysis (DIAGRAM) Consortium; Multiple Tissue Human Expression Resource (MUTHER) Consortium. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012;44:659-669.
13. Goodarzi MO, Langefeld CD, Xiang AH, et al. Insulin sensitivity and insulin clearance are heritable and have strong genetic correlation in Mexican Americans. Obesity (Silver Spring) 2014;22:1157-1164.
14. Below JE, Gamazon ER, Morrison JV, et al. Genome-wide association and meta- Analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals. Diabetologia 2011;54:2047-2055.
15. Williams AL, Jacobs SB, Moreno-Macias H, et al.; SIGMA Type 2 Diabetes Consortium. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2014;506:97-101.
16. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and prediabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009;32:287-294.
17. Henkin L, Bergman RN, Bowden DW, et al. Genetic epidemiology of insulin resistance and visceral adiposity. The IRAS Family Study design and methods. Ann Epidemiol 2003;13:211-217.
18. Watanabe RM, Allayee H, Xiang AH, et al. Transcription factor 7-like 2 (TCF7L2) is associated with gestational diabetes mellitus and interacts with adiposity to alter insulin secretion in Mexican Americans. Diabetes 2007;56: 1481-1485.
19. Goodarzi MO, Guo X, Taylor KD, et al. Determination and use of haplotypes: Ethnic comparison and association of the lipoprotein lipase gene and coronary artery disease in Mexican-Americans. Genet Med 2003;5:322-327.
20. Wang Y-P, Kandeel F, Taylor KD, et al. Insulin and blood pressure are linked to the LDL receptor-related protein locus on chromosome 12q (Abstract). Diabetes 2000;49(Suppl. 1):A204.
21. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic betacell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002;51:2796-2803.
22. Pacini G, Bergman RN. MINMOD: A computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23:113-122.
23. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
24. Welch S, Gebhart SS, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990;71:1508-1518.
25. Steil GM, Volund A, Kahn SE, Bergman RN. Reduced sample number for calculation of insulin sensitivity and glucose effectiveness from the minimal model. Suitability for use in population studies. Diabetes 1993;42: 250-256.
26. Polonsky KS, Pugh W, Jaspan JB, et al. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. J Clin Invest 1984;74:1821-1829.
27. Shen R, Fan JB, Campbell D, et al. High- Throughput SNP genotyping on universal bead arrays. Mutat Res 2005;573:70-82.
28. Gunderson KL, Steemers FJ, Ren H, et al. Whole-genome genotyping. Methods Enzymol 2006;410:359-376.
29. Grove ML, Yu B, Cochran BJ, et al. Best practices and joint calling of the HumanExome BeadChip: The CHARGE Consortium. PLoS One 2013;8:e68095.
30. Chen MH, Yang Q. GWAF: An R package for genome-wide association analyses with family data. Bioinformatics 2010;26:580-581.
31. Almasy L, Blangero J. Multipoint quantitative- Trait linkage analysis in general pedigrees. Am J Hum Genet 1998;62:1198-1211.
32. Hanley AJ, Wagenknecht LE, Norris JM, et al. Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: The Insulin Resistance Atherosclerosis Study (IRAS) Family study. Diabetologia 2009;52: 2079-2086.
33. GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013;45:580-585.
34. Rung J, Cauchi S, Albrechtsen A, et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet 2009;41:1110-1115.
35. Prokopenko I, Langenberg C, Florez JC, et al. Variants in MTNR1B influence fasting glucose levels. Nat Genet 2009;41:77-81.
36. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007;447:661-678.
37. Saxena R, Voight BF, Lyssenko V, et al.; Diabetes Genetics Initiative of Broad Institute of Harvard and MIT; Lund University; Novartis Institutes of BioMedical Research. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 2007;316:1331-1336.
38. Lyssenko V, Nagorny CL, Erdos MR, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 2009;41:82-88.
39. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979;236:E667-E677.
40. Ader M, Pacini G, Yang YJ, Bergman RN. Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements. Diabetes 1985;34:1092-1103.
41. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989;38:1512-1527.
42. Best JD, Kahn SE, Ader M, Watanabe RM, Ni TC, Bergman RN. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 1996;19:1018-1030.
43. Lorenzo C, Wagenknecht LE, Rewers MJ, et al. Disposition index, glucose effectiveness, and conversion to type 2 diabetes: The Insulin Resistance Atherosclerosis Study (IRAS). Diabetes Care 2010;33:2098-2103.
44. Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med 2013;34:121-138.
45. Watanabe RM. The genetics of insulin resistance: Where's Waldo? Curr Diab Rep 2010;10:476-484.
46. Goodarzi MO, Cui J, Chen YD, Hsueh WA, Guo X, Rotter JI. Fasting insulin reflects heterogeneous physiological processes: Role of insulin clearance. Am J Physiol Endocrinol Metab 2011;301:E402-E408.
47. Saxena R, Hivert MF, Langenberg C, et al.; GIANT Consortium; MAGIC Investigators. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet 2010;42:142-148.
48. Grarup N, Sparsø T, Hansen T. Physiologic characterization of type 2 diabetes-related loci. Curr Diab Rep 2010;10:485-497.
49. Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987;79:790-800.
50. Ernst J, Kheradpour P, Mikkelsen TS, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011;473:43-49.
51. Kong AM, Speed CJ, O'Malley CJ, et al. Cloning and characterization of a 72-kDa inositol-polyphosphate 5-phosphatase localized to the Golgi network. J Biol Chem 2000;275:24052-24064.